Alkeon Capital Management - MERSANA THERAPEUTICS INC ownership

MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 137 filers reported holding MERSANA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.90 and the average weighting 0.2%.

Quarter-by-quarter ownership
Alkeon Capital Management ownership history of MERSANA THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$16,973,000
-30.8%
1,799,838
-0.4%
0.03%
-19.4%
Q2 2021$24,529,000
-16.3%
1,806,267
-0.2%
0.04%
-18.2%
Q1 2021$29,294,000
-39.0%
1,810,505
+0.3%
0.04%
-43.6%
Q4 2020$48,027,000
+66.4%
1,804,828
+16.4%
0.08%
+47.2%
Q3 2020$28,861,0001,550,0000.05%
Other shareholders
MERSANA THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Sarissa Capital Management LP 4,005,600$64,810,0006.21%
Bain Capital Life Sciences Investors, LLC 3,695,667$59,796,0003.39%
COMMODORE CAPITAL LP 429,228$6,945,0002.77%
ACUTA CAPITAL PARTNERS, LLC 357,689$5,787,0002.09%
Avoro Capital Advisors LLC 6,800,000$110,024,0001.90%
Ghost Tree Capital, LLC 450,000$7,281,0001.71%
RHO CAPITAL PARTNERS INC 796,458$12,887,0001.24%
Rock Springs Capital Management LP 2,775,127$44,902,0000.98%
Sio Capital Management, LLC 157,259$2,544,0000.52%
Bellevue Group AG 2,850,010$46,113,0000.49%
View complete list of MERSANA THERAPEUTICS INC shareholders